SCHEMBL7540135

SCHEMBL7540135

NC(=O)Nc1ccc(C(=O)O)cc1C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTC4S Q16873 1/20 0.51
AKR1C3 P42330 6/20 0.49
AKR1C2 P52895 6/20 0.49
KDM4E B2RXH2 2/20 0.49
SERPINE1 P05121 2/20 0.48
AKR1B10 O60218 1/20 0.48
AKR1B1 P15121 1/20 0.48
AKR1C4 P17516 1/20 0.48
AKR1C1 Q04828 1/20 0.48
MEN1 O00255 4/20 0.47
MAPT P10636 4/20 0.47
KMT2A Q03164 4/20 0.47
TDP1 Q9NUW8 3/20 0.47
ALDH1A1 P00352 2/20 0.47
HTT P42858 1/20 0.47
HSD17B10 Q99714 2/20 0.47
NPC1 O15118 1/20 0.47
GAA P10253 1/20 0.47
THRB P10828 1/20 0.47
HPGD P15428 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25235287 0.85 AKR1B10 (0.49) AKR1C3AKR1C2KDM4EAKR1B10AKR1B1
SCHEMBL3896652 0.84 AKR1B10 (0.47) AKR1C3AKR1C2KDM4EAKR1B10AKR1B1
SCHEMBL3896659 0.84 AKR1B10 (0.47) AKR1C3AKR1C2KDM4EAKR1B10AKR1B1
SCHEMBL28253565 0.83 KMT2A (0.57) LTC4SKDM4EMEN1MAPTKMT2A
SCHEMBL31202243 0.82 MAPT (0.61) AKR1C3AKR1C2KDM4EAKR1B10AKR1B1
SCHEMBL15067280 0.82 MEN1 (0.72) LTC4SAKR1C3AKR1C2SERPINE1AKR1C4
SCHEMBL7542875 0.81 KDM5A (0.59) KDM4EMEN1MAPTKMT2AALDH1A1
SCHEMBL12700346 0.81 HSD17B10 (0.61) LTC4SAKR1C3AKR1C2KDM4ESERPINE1
SCHEMBL7259309 0.80 KDM4E (0.70) AKR1C3AKR1C2KDM4ESERPINE1AKR1C4
SCHEMBL7544693 0.80 KDM4E (0.59) AKR1C3AKR1C2KDM4EAKR1C4AKR1C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020094993-A1 Compositions for repelling crawling insects S.C. JOHNSON & SON, INC. 2002-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020094993-A1 Compositions for repelling crawling insects ACHE, DDT, GAP43 LTC4S 2282/4885AKR1C3 3064/4885AKR1C2 4005/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.